Hepatitis C virus infection in san francisco’s HIV-infected urban poor
- 1 April 2004
- journal article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 19 (4) , 357-365
Abstract
OBJECTIVE: To measure Hepatitis C Virus (HCV) prevalence, incidence, and initiation of HCV therapy in a representative HIV-infecteKeywords
This publication has 73 references indexed in Scilit:
- Trends in Causes of Death among Persons with Acquired Immunodeficiency Syndrome in the Era of Highly Active Antiretroviral Therapy, San Francisco, 1994–1998The Journal of Infectious Diseases, 2002
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsHepatology, 2002
- Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?New England Journal of Medicine, 2001
- Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San FranciscoHepatology, 2001
- Effect of Coexisting HIV-1 Infection on the Diagnosis and Evaluation of Hepatitis C VirusJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Camparison of the severity of liver disease in HCV-non-HIV-infected patients and HCV-HIV co-infected patients prfor to HCV-treatment in an urban areaGastroenterology, 2001
- Health Promotion in the City: A Review of Current Practice and Future Prospects in the United StatesAnnual Review of Public Health, 2000
- Depression and use of mental health services among HIV-infected menAIDS Care, 1996
- Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban CommunityNew England Journal of Medicine, 1994
- Treatment Modality and Quality Differences for Black and White Breast-Cancer Patients Treated in Community HospitalsMedical Care, 1989